RJFSA
SBIO icon

Raymond James Financial Services Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-66,307
Closed -$2.09M – 3333
2023
Q2 		$2.09M Sell
66,307
-7,032
-10% -$218K ﹤0.01% 1491
2023
Q1 		$1.99M Buy
73,339
+489
+0.7% +$14.8K ﹤0.01% 1497
2022
Q4 		$2.21M Sell
72,850
-4,341
-6% -$131K ﹤0.01% 1384
2022
Q3 		$2.33M Buy
77,191
+836
+1% +$26.4K 0.01% 1342
2022
Q2 		$2.11M Buy
76,355
+48,592
+175% +$1.39M ﹤0.01% 1406
2022
Q1 		$934K Buy
27,763
+6,757
+32% +$234K ﹤0.01% 2004
2021
Q4 		$887K Sell
21,006
-1,158
-5% -$51.6K ﹤0.01% 2047
2021
Q3 		$1.01M Sell
22,164
-329
-1% -$15.1K ﹤0.01% 1950
2021
Q2 		$1.1M Sell
22,493
-43
-0.2% -$2.06K ﹤0.01% 1885
2021
Q1 		$1.13M Buy
22,536
+1,371
+6% +$75.9K ﹤0.01% 1766
2020
Q4 		$1.08M Sell
21,165
-902
-4% -$42.9K ﹤0.01% 1647
2020
Q3 		$908K Buy
22,067
+935
+4% +$38.6K ﹤0.01% 1609
2020
Q2 		$884K Sell
21,132
-144
-0.7% -$5.68K ﹤0.01% 1570
2020
Q1 		$674K Buy
21,276
+394
+2% +$15.1K ﹤0.01% 1388
2019
Q4 		$883K Buy
20,882
+808
+4% +$30K ﹤0.01% 1612
2019
Q3 		$634K Buy
20,074
+2,556
+15% +$89.8K ﹤0.01% 1746
2019
Q2 		$633K Buy
17,518
+1,900
+12% +$65.5K ﹤0.01% 1771
2019
Q1 		$565K Buy
15,618
+788
+5% +$26.3K ﹤0.01% 1815
2018
Q4 		$417K Buy
14,830
+2,143
+17% +$71.1K ﹤0.01% 1790
2018
Q3 		$499K Buy
12,687
+2,345
+23% +$88.9K ﹤0.01% 1914
2018
Q2 		$385K Buy
10,342
+1,105
+12% +$40.1K ﹤0.01% 2062
2018
Q1 		$316K Buy
9,237
+2,753
+42% +$96.5K ﹤0.01% 1998
2017
Q4 		$213K Buy
+6,484
New +$203K ﹤0.01% 2224

Other funds holding SBIO

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial Services Advisors's SBIO Position: Q3 2023 in Review

Raymond James Financial Services Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2023, closing a stake of 66,307 shares — an estimated $2.09M sold.

Raymond James Financial Services Advisors first reported a position in SBIO in Q4 2017 and held it in 23 quarters. The position peaked at $2.33M in Q3 2022. 36 funds tracked by Wall St. Rank hold SBIO as of Q3 2023.

  • Raymond James Financial Services Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 66,307 ALPS Medical Breakthroughs ETF shares in Q3 2023, an estimated $2.09M.
  • Raymond James Financial Services Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2017 and held it in 23 quarters.
  • Raymond James Financial Services Advisors's ALPS Medical Breakthroughs ETF position peaked at $2.33M in Q3 2022.
  • 36 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.